Bioxytran, Inc (BIXT) stock
BIXTOTCPharmaceutical PreparationsFiscal year ends December 31
$0.02−0.00 (-3.95%)
Close on Oct 19, 2026Market cap $2.56MP/E –Yield –
Bioxytran cash
Cash and short-term investments held at the end of each period.
Bioxytran's cash was $177.38K at Jun 30, 2026. For fiscal 2025 it was $509.91K, up 9793.6% from the year before. Over ten years it grew 64.7% a year on average. The highest annual figure on record is $509.91K in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $509.91K | +9793.6% |
| FY2024 | Dec 31, 2024 | $5.15K | -80.2% |
| FY2023 | Dec 31, 2023 | $26.09K | -91.2% |
| FY2022 | Dec 31, 2022 | $295.40K | +308.2% |
| FY2021 | Dec 31, 2021 | $72.36K | +73.6% |
| FY2020 | Dec 31, 2020 | $41.69K | -75.4% |
| FY2019 | Dec 31, 2019 | $169.63K | +365.9% |
| FY2018 | Dec 31, 2018 | $36.41K | +33000.9% |
| FY2017 | Dec 31, 2017 | $110 | -99.0% |
| FY2016 | Dec 31, 2016 | $11.09K | +218.6% |
| FY2015 | Dec 31, 2015 | $3.48K | -43.6% |
| FY2014 | Dec 31, 2014 | $6.17K | -70.2% |
| FY2013 | Dec 31, 2013 | $20.69K | +274.6% |
| FY2012 | Dec 31, 2012 | $5.52K | -66.6% |
| FY2011 | Dec 31, 2011 | $16.51K | -27.4% |
| FY2010 | Dec 31, 2010 | $22.76K | +297.3% |
| FY2009 | Dec 31, 2009 | $5.73K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $177.38K | +5542.0% |
| Q1 FY2026 | Mar 31, 2026 | $463.05K | +10549.7% |
| Q4 FY2025 | Dec 31, 2025 | $509.91K | +9793.6% |
| Q3 FY2025 | Sep 30, 2025 | $14.50K | -58.2% |
| Q2 FY2025 | Jun 30, 2025 | $3.14K | -76.7% |
| Q1 FY2025 | Mar 31, 2025 | $4.35K | -56.6% |
| Q4 FY2024 | Dec 31, 2024 | $5.15K | -80.2% |
| Q3 FY2024 | Sep 30, 2024 | $34.67K | -56.8% |
| Q2 FY2024 | Jun 30, 2024 | $13.52K | -70.1% |
| Q1 FY2024 | Mar 31, 2024 | $10.02K | -93.5% |
| Q4 FY2023 | Dec 31, 2023 | $26.09K | -91.2% |
| Q3 FY2023 | Sep 30, 2023 | $80.27K | -78.5% |
| Q2 FY2023 | Jun 30, 2023 | $45.18K | -91.0% |
| Q1 FY2023 | Mar 31, 2023 | $153.80K | -79.2% |
| Q4 FY2022 | Dec 31, 2022 | $295.40K | +308.2% |
| Q3 FY2022 | Sep 30, 2022 | $374.19K | +53.4% |
| Q2 FY2022 | Jun 30, 2022 | $500.68K | +29.0% |
| Q1 FY2022 | Mar 31, 2022 | $739.58K | +707.1% |
| Q4 FY2021 | Dec 31, 2021 | $72.36K | +73.6% |
| Q3 FY2021 | Sep 30, 2021 | $243.99K | +38445.7% |
| Q2 FY2021 | Jun 30, 2021 | $388.04K | +9039.0% |
| Q1 FY2021 | Mar 31, 2021 | $91.64K | +108.8% |
| Q4 FY2020 | Dec 31, 2020 | $41.69K | -75.4% |
| Q3 FY2020 | Sep 30, 2020 | $633 | -98.1% |
| Q2 FY2020 | Jun 30, 2020 | $4.25K | -90.6% |
| Q1 FY2020 | Mar 31, 2020 | $43.89K | -63.1% |
| Q4 FY2019 | Dec 31, 2019 | $169.63K | +365.9% |
| Q3 FY2019 | Sep 30, 2019 | $33.23K | +1073.6% |
| Q2 FY2019 | Jun 30, 2019 | $45.28K | +129268.6% |
| Q1 FY2019 | Mar 31, 2019 | $118.93K | +396336.7% |
| Q4 FY2018 | Dec 31, 2018 | $36.41K | +33000.9% |
| Q3 FY2018 | Sep 30, 2018 | $2.83K | -87.9% |
| Q2 FY2018 | Jun 30, 2018 | $35 | -98.9% |
| Q1 FY2018 | Mar 31, 2018 | $30 | -99.7% |
| Q4 FY2017 | Dec 31, 2017 | $110 | -99.4% |
| Q3 FY2017 | Sep 30, 2017 | $23.45K | – |
| Q1 FY2017 | Mar 31, 2017 | $3.05K | – |
| Q4 FY2016 | Dec 31, 2016 | $11.09K | – |
| Q3 FY2016 | Sep 30, 2016 | $18.77K | – |
See a number that looks wrong?